Rescue of myogenic defects in Rb-deficient cells by inhibition of autophagy or by hypoxia-induced glycolytic shift

Journal of Cell Biology

Volumn 191, Issue 2, 2010, Pages 291-301

  Ciavarra, Giovanni ^a   Zacksenhaus, Eldad ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL AGGREGATION; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; EMBRYO; ENZYME SYNTHESIS; GLYCOLYSIS; MOUSE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL DIFFERENTIATION; CELL HYPOXIA; CELLS, CULTURED; GLYCOLYSIS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MITOCHONDRIA; MUSCLE FIBERS, SKELETAL; MYOBLASTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN;

EID: 77958469448     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.201005067     Document Type: Article

References (59)

1. Amthor, H., R. Macharia, R. Navarrete, M. Schuelke, S.C. Brown, A. Otto, T. Voit, F. Muntoni, G. Vrbóva, T. Partridge, et al. 2007. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc. Natl. Acad. Sci. USA. 104:1835-1840. doi:10.1073/pnas.0604893104
2. Bampton, E.T., C.G. Goemans, D. Niranjan, N. Mizushima, and A.M. Tolkovsky. 2005. The dynamics of autophagy visualized in live cells: from autophagosome formation to fusion with endo/lysosomes. Autophagy. 1:23-36. doi:10.4161/auto.1.1.1495
3. Bastin, J., F. Aubey, A. Rötig, A. Munnich, and F. Djouadi. 2008. Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. J. Clin. Endocrinol. Metab. 93:1433-1441. doi:10.1210/jc.2007-1701
4. Benevolenskaya, E.V., H.L. Murray, P. Branton, R.A. Young, and W.G. Kaelin Jr. 2005. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol. Cell. 18:623-635. doi:10.1016/j.molcel.2005.05.012
5. Bremner, R., and E. Zacksenhaus. 2010. Cyclins, Cdks, E2f, Skp2, and more at the first international RB Tumor Suppressor Meeting. Cancer Res. 70:6114-6118. doi:10.1158/0008-5472.CAN-10-0358
6. Briaud, I., L.M. Dickson, M.K. Lingohr, J.F. McCuaig, J.C. Lawrence, and C.J. Rhodes. 2005. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells. J. Biol. Chem. 280:2282-2293. doi:10.1074/jbc.M412179200
7. Burkhart, D.L., and J. Sage. 2008. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat. Rev. Cancer. 8:671-682. doi:10.1038/nrc2399
8. Chen, T.T., and J.Y. Wang. 2000. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function. Mol. Cell. Biol. 20:5571-5580. doi:10.1128/MCB.20.15.5571-5580.2000
9. Chen, D., I. Livne-bar, J.L. Vanderluit, R.S. Slack, M. Agochiya, and R. Bremner. 2004. Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell. 5:539-551. doi:10.1016/j.ccr.2004.05.025
10. Chen, H.Z., S.Y. Tsai, and G. Leone. 2009. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat. Rev. Cancer. 9:785-797. doi:10.1038/nrc2696
11. Dang, C.V., A. Le, and P. Gao. 2009. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res. 15:6479-6483. doi:10.1158/1078-0432.CCR-09-0889
12. Darville, M.I., I.V. Antoine, J.R. Mertens-Strijthagen, V.J. Dupriez, and G.G. Rousseau. 1995. An E2F-dependent late-serum-response promoter in a gene that controls glycolysis. Oncogene. 11:1509-1517.
13. Di Carlo, A., R. De Mori, F. Martelli, G. Pompilio, M.C. Capogrossi, and A. Germani. 2004. Hypoxia inhibits myogenic differentiation through accelerated MyoD degradation. J. Biol. Chem. 279:16332-16338. doi:10.1074/jbc.M313931200
14. Gu, W., J.W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell. 72:309-324. doi:10.1016/0092-8674(93)90110-C (Pubitemid 23059403)
15. Guo, Z., S. Yikang, H. Yoshida, T.W. Mak, and E. Zacksenhaus. 2001. Inactivation of the retinoblastoma tumor suppressor induces apoptosis proteaseactivating factor-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res. 61:8395-8400. (Pubitemid 33131113)
16. Hershko, T., and D. Ginsberg. 2004. Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J. Biol. Chem. 279:8627-8634. doi:10.1074/jbc.M312866200 (Pubitemid 38295917)
17. Ho, A.T., Q.H. Li, R. Hakem, T.W. Mak, and E. Zacksenhaus. 2004. Coupling of caspase-9 to Apaf1 in response to loss of pRb or cytotoxic drugs is cell-type-specific. EMBO J. 23:460-472. doi:10.1038/sj.emboj.7600039
18. Ho, A.T., Q.H. Li, H. Okada, T.W. Mak, and E. Zacksenhaus. 2007. XIAP activity dictates Apaf-1 dependency for caspase 9 activation. Mol. Cell. Biol. 27:5673-5685.
19. Huh, M.S., M.H. Parker, A. Scimè, R. Parks, and M.A. Rudnicki. 2004. Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation. J. Cell Biol. 166:865-876. doi:10.1083/jcb.200403004
20. Jiang, Z., and E. Zacksenhaus. 2002. Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma. J. Cell Biol. 156:185-198. doi:10.1083/jcb.200106084
21. Jiang, Z., P. Liang, R. Leng, Z. Guo, Y. Liu, X. Liu, S. Bubnic, A. Keating, D. Murray, P.E. Goss, and E. Zacksenhaus. 2000. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis. Dev. Biol. 227:8-41. doi:10.1006/dbio.2000.9892
22. Jiang, Z., Z. Guo, F.A. Saad, J. Ellis, and E. Zacksenhaus. 2001. Retinoblastoma gene promoter directs transgene expression exclusively to the nervous system. J. Biol. Chem. 276:593-600. doi:10.1074/jbc.M005474200
23. Jiang, Z., T. Deng, R. Jones, H. Li, J.I. Herschkowitz, J.C. Liu, V.J. Weigman, M.S. Tsao, T.F. Lane, C.M. Perou, and E. Zacksenhaus. 2010. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. J. Clin. Invest. 120:3296-3309. doi:10.1172/JCI41490
24. Lasorella, A., M. Noseda, M. Beyna, Y. Yokota, and A. Iavarone. 2000. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature. 407:592-598. doi:10.1038/35036504
25. Leonard, K.C., D. Petrin, S.G. Coupland, A.N. Baker, B.C. Leonard, E.C. LaCasse, W.W. Hauswirth, R.G. Korneluk, and C. Tsilfidis. 2007. XIAP protection of photoreceptors in animal models of retinitis pigmentosa. PLoS One. 2:e314. doi:10.1371/journal.pone.0000314
26. Levine, B., and G. Kroemer. 2008. Autophagy in the pathogenesis of disease. Cell. 132:27-42. doi:10.1016/j.cell.2007.12.018
27. Maandag, E.C., M. van der Valk, M. Vlaar, C. Feltkamp, J. O'Brien, M. van Roon, N. van der Lugt, A. Berns, and H. te Riele. 1994. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13:4260-4268.
28. MacLellan, W.R., G. Xiao, M. Abdellatif, and M.D. Schneider. 2000. A novel Rb- and p300-binding protein inhibits transactivation by MyoD. Mol. Cell. Biol. 20:8903-8915. doi:10.1128/MCB.20.23.8903-8915.2000
29. Mammucari, C., G. Milan, V. Romanello, E. Masiero, R. Rudolf, P. Del Piccolo, S.J. Burden, R. Di Lisi, C. Sandri, J. Zhao, et al. 2007. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 6:458-471. doi:10.1016/j.cmet.2007.11.001
30. Mantela, J., Z. Jiang, J. Ylikoski, B. Fritzsch, E. Zacksenhaus, and U. Pirvola. 2005. The retinoblastoma gene pathway regulates the postmitotic state of hair cells of the mouse inner ear. Development. 132:2377-2388 doi:10.1242/dev.01834. (Pubitemid 40872807)
31. Maynard, M.A., and M. Ohh. 2007. The role of hypoxia-inducible factors in cancer. Cell. Mol. Life Sci. 64:2170-2180. doi:10.1007/s00018-007-7082-2
32. Mizushima, N. 2009. Physiological functions of autophagy. Curr. Top. Microbiol. Immunol. 335:71-84. doi:10.1007/978-3-642-00302-8-3
33. Mizushima, N., and T. Yoshimori. 2007. How to interpret LC3 immunoblotting. Autophagy. 3:542-545.
34. Mizushima, N., T. Yoshimori, and B. Levine. 2010. Methods in mammalian autophagy research. Cell. 140:313-326. doi:10.1016/j.cell.2010.01.028
35. Morselli, E., L. Galluzzi, O. Kepp, J.M. Vicencio, A. Criollo, M.C. Maiuri, and G. Kroemer. 2009. Anti- and pro-tumor functions of autophagy. Biochim. Biophys. Acta. 1793:1524-1532. doi:10.1016/j.bbamcr.2009.01.006
36. Nahle, Z., J. Polakoff, R.V. Davuluri, M.E. McCurrach, M.D. Jacobson, M. Narita, M.Q. Zhang, Y. Lazebnik, D. Bar-Sagi, and S.W. Lowe. 2002. Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 4:859-864. doi:10.1038/ncb868 (Pubitemid 35331360)
37. Narendra, D., A. Tanaka, D.F. Suen, and R.J. Youle. 2008. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183:795-803. doi:10.1083/jcb.200809125
38. Novitch, B.G., D.B. Spicer, P.S. Kim, W.L. Cheung, and A.B. Lassar. 1999. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol. 9:449-459. doi:10.1016/S0960-9822(99)80210-3
39. Pattingre, S., and B. Levine. 2006. Bcl-2 inhibition of autophagy: a new route to cancer? Cancer Res. 66:2885-2888. doi:10.1158/0008-5472.CAN-05-4412
40. Pelicano, H., D.S. Martin, R.H. Xu, and P. Huang. 2006. Glycolysis inhibition for anticancer treatment. Oncogene. 25:4633-4646. doi:10.1038/sj.onc.1209597
41. Polager, S., M. Ofir, and D. Ginsberg. 2008. E2F1 regulates autophagy and the transcription of autophagy genes. Oncogene. 27:4860-4864. doi:10.1038/onc.2008.117
42. Puri, P.L., S. Iezzi, P. Stiegler, T.T. Chen, R.L. Schiltz, G.E. Muscat, A. Giordano, L. Kedes, J.Y. Wang, and V. Sartorelli. 2001. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol. Cell. 8:885-897. doi:10.1016/S1097-2765(01)00373-2 (Pubitemid 33030221)
43. Sankaran, V.G., S.H. Orkin, and C.R. Walkley. 2008. Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev. 22:463-475. doi:10.1101/gad.1627208
44. Schneider, J.W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard. 1994. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science. 264:1467-1471. doi:10.1126/science.8197461
45. Shimizu, S., T. Kanaseki, N. Mizushima, T. Mizuta, S. Arakawa-Kobayashi, C.B. Thompson, and Y. Tsujimoto. 2004. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 6:1221-1228. doi:10.1038/ncb1192
46. Skurk, C., Y. Izumiya, H. Maatz, P. Razeghi, I. Shiojima, M. Sandri, K. Sato, L. Zeng, S. Schiekofer, D. Pimentel, et al. 2005. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J. Biol. Chem. 280:20814-20823. doi:10.1074/jbc.M500528200
47. Sufan, R.I., E.H. Moriyama, A. Mariampillai, O. Roche, A.J. Evans, N.M. Alajez, I.A. Vitkin, V.X. Yang, F.F. Liu, B.C. Wilson, and M. Ohh. 2009. Oxygen-independent degradation of HIF-alpha via bioengineered VHL tumour suppressor complex. EMBO Mol Med. 1:66-78. doi:10.1002/emmm.200900004
48. Tolkovsky, A.M. 2009. Mitophagy. Biochim. Biophys. Acta. 1793:1508-1515. doi:10.1016/j.bbamcr.2009.03.002
49. Tracy, K., B.C. Dibling, B.T. Spike, J.R. Knabb, P. Schumacker, and K.F. Macleod. 2007. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol. Cell. Biol. 27:6229-6242. doi:10.1128/MCB.02246-06
50. Trincheri, N.F., C. Follo, G. Nicotra, C. Peracchio, R. Castino, and C. Isidoro. 2008. Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes. Carcinogenesis. 29:381-389. doi:10.1093/carcin/bgm271
51. Vander Heiden, M.G., L.C. Cantley, and C.B. Thompson. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 324:1029-1033. doi:10.1126/science.1160809
52. Vincent, K.A., K.G. Shyu, Y. Luo, M. Magner, R.A. Tio, C. Jiang, M.A. Goldberg, G.Y. Akita, R.J. Gregory, and J.M. Isner. 2000. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation. 102:2255-2261.
53. Vooijs, M., H. te Riele, M. van der Valk, and A. Berns. 2002. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells. Oncogene. 21:4635-4645. doi:10.1038/sj.onc.1205575
54. Wenz, T., F. Diaz, B.M. Spiegelman, and C.T. Moraes. 2008. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab. 8:249-256. doi:10.1016/j.cmet.2008.07.006
55. Williams, B.O., E.M. Schmitt, L. Remington, R.T. Bronson, D.M. Albert, R.A. Weinberg, and T. Jacks. 1994. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13:4251-4259.
56. Xue, L., G.C. Fletcher, and A.M. Tolkovsky. 2001. Mitochondria are selectively eliminated from eukaryotic cells after blockade of caspases during apoptosis. Curr. Biol. 11:361-365. doi:10.1016/S0960-9822(01)00100-2
57. Zacksenhaus, E., Z. Jiang, D. Chung, J.D. Marth, R.A. Phillips, and B.L. Gallie. 1996. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10:3051-3064. doi:10.1101/gad.10.23.3051
58. Zhao, J., J.J. Brault, A. Schild, P. Cao, M. Sandri, S. Schiaffino, S.H. Lecker, and A.L. Goldberg. 2007. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 6:472-483. doi:10.1016/j.cmet.2007.11.004 (Pubitemid 350163056)
59. Zhu, S., I.G. Stavrovskaya, M. Drozda, B.Y. Kim, V. Ona, M. Li, S. Sarang, A.S. Liu, D.M. Hartley, D.C. Wu, et al. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 417:74-78. doi:10.1038/417074a